Related Experiment Video
Updated: Jun 20, 2026
Preterm EEG: A Multimodal Neurophysiological Protocol
Published on: February 18, 2012
Individualized developmental care for a large sample of very preterm infants: health, neurobehaviour and
G McAnulty1, F H Duffy, S Butler
1Department of Psychiatry (Psychology), Children's Hospital Boston and Harvard Medical School, Boston, MA, USA.
Insights
The Newborn Individualized Developmental Care and Assessment Program (NIDCAP) significantly reduces medical issues and improves neurodevelopmental outcomes for very preterm infants. This care enhances functional competence and quality of life up to nine months corrected age.
Area of Science:
- Neonatal care
- Developmental pediatrics
- Neuroscience
Background:
- Very early-born infants (<29 weeks GA) face significant medical and neurodevelopmental challenges.
- Individualized developmental care approaches aim to mitigate these risks.
Purpose of the Study:
- To evaluate the medical and neurodevelopmental effects of the Newborn Individualized Developmental Care and Assessment Program (NIDCAP).
- To assess outcomes in a large cohort of very preterm infants.
Main Methods:
- Randomized controlled trial involving 107 singleton preterm infants (<29 weeks GA, <1250 g).
- Infants were randomized to NIDCAP (E) or standard care (C) from NICU admission to 2 weeks corrected age (wCA).
- Outcomes assessed included medical status, neurobehavior, and neurophysiology at 2 wCA, and growth and neurobehavior at 9 months (m) CA.
Main Results:
- The NIDCAP group (E) showed a significant reduction in major medical morbidities of prematurity compared to standard care (C).
- Significantly improved neurodevelopmental functioning (behavior and electrophysiology) was observed at 2 wCA in the E-group.
- Enhanced neurobehavioral functioning persisted at 9 mCA for infants receiving NIDCAP.
Conclusions:
- NIDCAP is an effective intervention for very early-born infants.
- The program demonstrably reduces health morbidities.
- NIDCAP enhances neurodevelopment, functional competence, and quality of life for preterm infants at 2 weeks and 9 months corrected age.
Aim:
To assess medical and neurodevelopmental effects of Newborn Individualized Developmental Care and Assessment Program (NIDCAP) for a large sample of very early-born infants.
Methods:
One hundred and seven singleton inborn preterm infants, <29 weeks gestational age (GA), <1250 g birth weight, enrolled in three consecutive phases, were randomized within phase to NIDCAP (treatment, E) or standard care (C). Treatment extended from admission to the Newborn Intensive Care Unit to 2 weeks corrected age (wCA). Outcome included medical, neurobehavioural and neurophysiological status at 2 wCA, and growth and neurobehavioural status at 9 months (m) CA.
Results:
The C- and E-group within each of the three consecutive phases and across the three phases were comparable in terms of all background measures; they therefore were treated as one sample. The results indicated for the E-group significant reduction in major medical morbidities of prematurity as well as significantly improved neurodevelopmental (behaviour and electrophysiology) functioning at 2 wCA; significantly better neurobehavioural functioning was also found at 9 mCA.
Conclusion:
The NIDCAP is an effective treatment for very early-born infants. It reduces health morbidities and enhances neurodevelopment, functional competence and life quality for preterm infants at 2 w and 9 mCA.
